Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
暂无分享,去创建一个
K. Sleegers | C. van Broeckhoven | S. Engelborghs | R. Vandenberghe | R. Sciot | P. D. De Deyn | M. Cruts | J. Theuns | S. Serneels | P. Cras | N. Brouwers | P. Santens | J. van der Zee | B. Pickut | B. Dermaut | S. Kumar-Singh | Jean-Jacques Martin | M. van den Broeck | Tim De Pooter | I. Cuijt | K. Peeters | K. Nuytemans | I. Gijselinck | P. Pals | V. Bogaerts | M. Mattheijssens | Ivy Cuijt | P. D. de Deyn | M. Van den Broeck | Veerle Bogaerts | Maria Mattheijssens | Karen Nuytemans
[1] K. Sleegers,et al. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia , 2007, Human mutation.
[2] S. Melquist,et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. , 2006, Human molecular genetics.
[3] S. Engelborghs,et al. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease , 2005, International journal of geriatric psychiatry.
[4] C. Broeckhoven,et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.
[5] J. Steitz,et al. Human Upf Proteins Target an mRNA for Nonsense-Mediated Decay When Bound Downstream of a Termination Codon , 2000, Cell.
[6] P. Cras,et al. Case–control study of environmental risk factors for Parkinson's disease in Belgium , 2002, European Journal of Epidemiology.
[7] D. Bennett,et al. Progression of parkinsonism and loss of cognitive function in Alzheimer disease. , 2000, Archives of neurology.
[8] C. Duijn,et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval , 2002, Molecular Psychiatry.
[9] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[10] J. Morris,et al. Neuropathologic Heterogeneity in HDDD1: A Familial Frontotemporal Lobar Degeneration With Ubiquitin-positive Inclusions and Progranulin Mutation , 2007, Alzheimer disease and associated disorders.
[11] C. van Broeckhoven,et al. Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum. , 2005, Trends in genetics : TIG.
[12] C. van Broeckhoven,et al. Characterization of Ubiquitinated Intraneuronal Inclusions in a Novel Belgian Frontotemporal Lobar Degeneration Family , 2006, Journal of neuropathology and experimental neurology.
[13] S. Pickering-Brown. Progranulin and frontotemporal lobar degeneration , 2007, Acta Neuropathologica.
[14] P. Deyn,et al. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia , 2008, Neurobiology of Aging.
[15] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[16] A. Hofman,et al. A population-based study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21. , 1994, American Journal of Human Genetics.
[17] Zhiheng He,et al. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis , 2003, Journal of Molecular Medicine.
[18] P. Deyn,et al. Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF , 1999, Neurology.
[19] J. Morris,et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulin , 2006, Annals of neurology.
[20] C. van Broeckhoven,et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. , 2006, Brain : a journal of neurology.
[21] Ronald Peeters,et al. Anterior temporal laterality in primary progressive aphasia shifts to the right , 2005, Annals of neurology.
[22] P. Deyn,et al. Dose dependent effect of APOE ɛ4 on behavioral symptoms in frontal lobe dementia , 2006, Neurobiology of Aging.
[23] C. van Broeckhoven,et al. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. , 2006, Neurobiology of aging.
[24] A. Fagan,et al. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. , 2007, Archives of neurology.
[25] J. Cummings. Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates , 1988, Journal of geriatric psychiatry and neurology.
[26] C. van Broeckhoven,et al. novoSNP, a novel computational tool for sequence variation discovery. , 2005, Genome research.
[27] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.